← Back to signals
EW
STRONG BUYEdwards Lifesciences Corporation
Health Care
0.54
PEGY ratio
Rank #213
Why This Matters
This stock appears significantly undervalued relative to its growth and dividend yield. Strong projected growth of 85.6% annually over 5 years.
EW is trading at 46.5x earnings against 85.6% growth (no dividend), giving a PEGY of 0.54. The math suggests the stock is significantly undervalued relative to its growth and income profile.
~ Growth estimate uses historical CAGR (forward estimates unavailable)
- • Growth rate derived from historical CAGR — limited analyst coverage.
Scan date: 2026-04-24
Valuation
46.5x
P/E Ratio
Growth
85.6%
5yr EPS
Income
0.0%
Div Yield
PEGY Components
PEGY Score0.54
Denominator85.6%
EPS (TTM)$1.81
Market Data
Price$84.15
ExchangeNYSE
S&P 500
What Changed
PEGY Score
0.54→0.54(+0.01)
Rank
#150→#213(63 positions)
vs 7 days ago
Portfolio Context
Founder does not hold this stock.
Not in your portfolio.
Sector: Health Care
PEGY History — 90 days
Data: Yahoo Finance • Updated nightly 11 PM ET • For informational purposes only